« Back
Home /
Carvedilol phosphate hemihydrate

Carvedilol phosphate hemihydrate

Item no.	TMO-T0342-50mg
Manufacturer	TargetMol
CASRN	610309-89-2
Amount	50 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 200 mg 25 mg 500 mg 50 mg 5 mg
Category	Oncology Neuroscience Metabolism Diabetes Glucose Homeostasis Neural Adhesion Molecules Reagents & Chemicals Molecules By Organ Bladder Cancer
Type	Molecules
Specific against	other
Purity	0,98
Smiles	O.OP(O)(O)=O.OP(O)(O)=O.COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	Carvedilol phosphate,BM 14190 (phosphate hemihydrate)
Similar products	610309-89-2
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Integrin\|\|\|LDL\|\|\|VEGFR\|\|\|Potassium Channel\|\|\|Gap Junction Protein\|\|\|NADPH\|\|\|Autophagy\|\|\|Adrenergic Receptor
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	513.49
Description	Carvedilol phosphate hemihydrate (BM 14190 phosphate hemihydrate) is the phosphate salt form of carvedilol, a racemic mixture and adrenergic blocking agent with antihypertensive activity and no intrinsic sympathomimetic activity.
Pathways	Angiogenesis\|\|\|Autophagy\|\|\|GPCR/G Protein\|\|\|Tyrosine Kinase/Adaptors\|\|\|Neuroscience\|\|\|Membrane transporter/Ion channel\|\|\|Cytoskeletal Signaling\|\|\|Metabolism

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T0342-50mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 50 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question